Targeted derepression of the human immunodeficiency virus type 1 long terminal repeat by pyrrole-imidazole polyamides.
about
sameAs
Therapeutic modulation of endogenous gene function by agents with designed DNA-sequence specificitiesDNA and the chromosome - varied targets for chemotherapyChromatin, non-coding RNAs, and the expression of HIVDepletion of latent HIV-1 infection in vivo: a proof-of-concept studyLatency reversal and viral clearance to cure HIV-1.Nuclear localization of pyrrole-imidazole polyamide-fluorescein conjugates in cell culture.Completion of a Programmable DNA-Binding Small Molecule LibraryBinding of Hoechst 33258 and its derivatives to DNA.Synergistic activation of HIV-1 expression by deacetylase inhibitors and prostratin: implications for treatment of latent infection.Glucose Deficiency Elevates Acid-Sensing Ion Channel 2a Expression and Increases Seizure Susceptibility in Temporal Lobe EpilepsyTranscription through the HIV-1 nucleosomes: effects of the PBAF complex in Tat activated transcriptionCell line-dependent variability in HIV activation employing DNMT inhibitorsCurcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription.Pharmaceutical approaches to eradication of persistent HIV infection.Effect of SWI/SNF chromatin remodeling complex on HIV-1 Tat activated transcription.Acute HIV revisited: new opportunities for treatment and prevention.Stable Phenotypic Changes of the Host T Cells Are Essential to the Long-Term Stability of Latent HIV-1 Infection.Lineage-specific and ubiquitous biological roles of the mammalian transcription factor LSFMechanisms of Yin Yang 1 in oncogenesis: the importance of indirect effects.HIV pharmacology: barriers to the eradication of HIV from the CNS.Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitorsHIV type-1 latency: targeted induction of proviral reservoirs.Function of YY1 in Long-Distance DNA Interactions.Chromatin dynamics associated with HIV-1 Tat-activated transcription.Cell cycle arrest in G2 induces human immunodeficiency virus type 1 transcriptional activation through histone acetylation and recruitment of CBP, NF-kappaB, and c-Jun to the long terminal repeat promoterMolecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.Programmable DNA-binding small molecules.Complex of the herpes simplex virus type 1 origin binding protein UL9 with DNA as a platform for the design of a new type of antiviral drugs.c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter.Mitogen-activated protein kinases regulate LSF occupancy at the human immunodeficiency virus type 1 promoter.Alternative heterocycles for DNA recognition: the benzimidazole/imidazole pair.Epigenetic regulation of HIV-1 latency: focus on polycomb group (PcG) proteins.
P2860
Q24644274-5D6BB327-9632-4B42-B640-80C3B0FF59F9Q24792540-F43530B4-C89A-47EE-945A-14D9234333C7Q27021127-5DD1F658-137E-4817-810F-D80B0C2BD717Q28111910-07EDFE63-8BEC-44CD-AD18-6BDC61BFCC2BQ30248766-81FBF423-E09E-493D-888C-B147C5B4994DQ33193534-A4F379ED-C0E3-4679-B2E7-39C9B84F9D2AQ33348532-2E8FE8D4-CA46-4BFD-8B8B-43768B695289Q33433618-A37A4BC5-49DD-4C8D-8E91-C32BB5118F07Q33476165-1B3BDA15-0DFA-417C-9794-101C228532FBQ33918957-15648C2D-8661-45E9-9AAE-04B3A43D7334Q34071895-1F2FB1CF-9EE0-4DF3-AA8A-CA6C79FFBC85Q34243934-FC90B843-9B2C-41C7-9A68-6926AF7C6DCEQ34350588-571996B2-C440-4908-A2F6-FF0A701F8B7FQ34941973-A770E241-E0F6-4A96-856D-4253842520B6Q35040154-A2C12100-DCE7-488D-A427-1EC713504961Q35730339-F61D74FE-EFD5-4D31-A3A4-257A69C03AF7Q35745365-198EE268-A18E-44A3-BFC4-A2B53AC8D688Q35962753-AB322D94-03C4-4D6D-B87B-B31F2D8DD7BCQ36157946-D1DEC294-44B4-409C-AFC7-BFE957D12333Q36552753-7D960ACC-D585-4D9E-80BF-619EA6A002BBQ37257484-C671ABB5-FB89-4ACC-8CEF-B6BF893FDC17Q37502488-0FB71C8A-CB15-4E62-AC1D-AF209180FE21Q37570810-C6375B71-2F41-46E6-85AF-8651D103AE48Q37589012-398C36E6-3AEE-440E-B4DB-A8D9682A436EQ37596980-4C60439C-F450-45D6-B9B8-E29FA4FB0FD6Q37644561-A2A4807C-E3FE-4D15-853F-95ED736C1724Q38105825-6CB22633-A8C5-456B-B3F5-9E37F74BBDADQ38313901-69F6FBDC-8AC8-4CB6-9069-E583433AB8D7Q42638819-CD7B6D1B-7C76-49B5-AE44-26416AEF2895Q42732128-A7B8CF9B-F2E5-4573-A057-F97F7E93FFEFQ44100468-35D3ECB2-A04E-48A5-B397-CC9174ADB086Q50022535-07E0DFC6-091D-4F90-9559-19C94601364A
P2860
Targeted derepression of the human immunodeficiency virus type 1 long terminal repeat by pyrrole-imidazole polyamides.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Targeted derepression of the h ...... y pyrrole-imidazole polyamides
@nl
Targeted derepression of the h ...... pyrrole-imidazole polyamides.
@ast
Targeted derepression of the h ...... pyrrole-imidazole polyamides.
@en
type
label
Targeted derepression of the h ...... y pyrrole-imidazole polyamides
@nl
Targeted derepression of the h ...... pyrrole-imidazole polyamides.
@ast
Targeted derepression of the h ...... pyrrole-imidazole polyamides.
@en
prefLabel
Targeted derepression of the h ...... y pyrrole-imidazole polyamides
@nl
Targeted derepression of the h ...... pyrrole-imidazole polyamides.
@ast
Targeted derepression of the h ...... pyrrole-imidazole polyamides.
@en
P2093
P2860
P1433
P1476
Targeted derepression of the h ...... pyrrole-imidazole polyamides.
@en
P2093
Christian Melander
Guocheng He
Jason J Coull
Victor C Rucker
P2860
P304
12349-12354
P356
10.1128/JVI.76.23.12349-12354.2002
P407
P577
2002-12-01T00:00:00Z